# Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

> clinical trial · VERIFIED · 2026-08-20

Status: ACTIVE_NOT_RECRUITING · Sponsor: Boehringer Ingelheim · Condition: Lung Cancer, Non-squamous, Non-small Cell

- Company: Boehringer Ingelheim
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06151574

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.